Related Experiment Video
Updated: Jul 15, 2025

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Uptake of the Gout and Crystal Arthritis Network Consensus Statements for Gout Nomenclature
Ellen Prendergast1, Nicola Dalbeth2, David Bursill3
1Te Whatu Ora Waitaha, Christchurch, New Zealand.
Insights
Adherence to Gout and Crystal Arthritis Network (G-CAN) nomenclature for gout has improved since 2019. However, the use of standardized gout terminology in scientific literature still requires further enhancement for clarity.
Area of Science:
- Rheumatology
- Crystal Arthropathies
- Medical Nomenclature
Background:
- The Gout and Crystal Arthritis Network (G-CAN) established consensus statements in 2019 for gout disease element and state nomenclature.
- Consistent terminology is crucial for clear scientific communication in rheumatology.
Purpose of the Study:
- To assess the adherence to G-CAN's consensus nomenclature statements for gout since their publication.
- To evaluate changes in the use of specific gout-related terms in scientific abstracts before and after the G-CAN statements were released.
Main Methods:
- A systematic search of American College of Rheumatology and EULAR conference abstracts was conducted.
- Abstracts published before (2016-2017) and after (2020-2021) the G-CAN statements were analyzed for the use of agreed-upon and alternative nomenclature for gout.
- Statistical comparisons were made between the two time periods to determine significant changes in term usage.
Main Results:
- Analysis included 988 abstracts (596 from 2016-2017, 392 from 2020-2021).
- The use of agreed labels 'urate' (57.2% to 70.7%) and 'gout flare' (34.3% to 52.3%) significantly increased post-publication (P < 0.001 and P < 0.003, respectively).
- The use of the label 'chronic gout' significantly decreased (4.9% to 2.0%, P = 0.02).
Conclusions:
- Adherence to G-CAN-agreed gout nomenclature has demonstrably increased in scientific abstracts.
- Despite improvements, the nomenclature used for gout remains imprecise, indicating a need for continued efforts.
- Further initiatives are necessary to ensure consistent and accurate application of gout nomenclature in scientific literature.
Objective:
In 2019, the Gout and Crystal Arthritis Network (G-CAN) published consensus statements for the nomenclature of disease elements and states in gout. The aim of this study was to determine adherence to the G-CAN consensus nomenclature statements since publication.
Methods:
American College of Rheumatology and EULAR conference abstracts were searched using online databases for the keywords 'gout,' 'urate,' 'uric acid,' 'hyperuricaemia,' 'tophus,' and/or 'tophi' before and after publication of the consensus statements (January 1, 2016 to December 31, 2017 and January 1, 2020 to December 31, 2021, respectively). Abstracts were manually searched for labels used to reference gout disease elements and states. Use of the G-CAN-agreed labels, as well as alternatives, were compared between the two time periods.
Results:
There were 988 abstracts included in the analysis: 596 in 2016 to 2017 and 392 in 2020 to 2021. Use of the agreed labels 'urate' and 'gout flare' increased between the two periods. There were 219 of 383 abstracts (57.2%) with the agreed label 'urate' in 2016 to 2017 compared with 164 of 232 (70.7%) in 2020 to 2021 (P = 0.001). There were 60 of 175 abstracts (34.3%) with the agreed label 'gout flare' in 2016 to 2017 compared with 57 of 109 (52.3%) in 2020 to 2021 (P = 0.003). Consistent with the G-CAN statement, use of the label 'chronic gout' reduced between the two time periods. There were 29 of 596 abstracts (4.9%) in 2016 to 2017 that used the label 'chronic gout' compared with 8 of 392 abstracts (2.0%) in 2020 to 2021 (P = 0.02).
Conclusion:
Use of G-CAN-agreed gout labels has increased, but gout nomenclature remains imprecise. Additional efforts are needed to ensure consistent use of agreed nomenclature for gout in the scientific literature.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Drug Nomenclature
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Crystal Growth: Principles of Crystallization
Initiating crystallization involves manipulating the concentration of the solute and the temperature of the solution. Since crystal growth occurs when the ratio of concentration and solubility of the solute in the solvent...
Urinary Tract Calculi III: Medical Management

